Tempus AI in Precision Medicine
Tempus AI builds one of the largest libraries of clinical and molecular data and applies machine learning to it, so doctors can match patients—especially cancer patients—to therapies based on the biology of their disease.
Overview
It matters because precision medicine replaces one-size-fits-all treatment with data-driven, individualized care.
Deep Dive
Founded in 2015 by Eric Lefkofsky, Tempus pairs genomic sequencing with vast amounts of de-identified clinical data to power precision medicine. When a tumor is sequenced, Tempus analyzes its DNA and RNA to find actionable mutations, then uses AI to connect those findings to relevant targeted therapies, immunotherapies, and clinical trials. Its scale comes from partnerships with hospitals and academic centers that contribute structured clinical records and pathology images, creating a feedback loop where real-world outcomes refine the models. Beyond oncology, Tempus has expanded into cardiology, neurology, and infectious disease, and offers algorithmic tests that flag patients who may benefit from specific interventions. The company also supports pharmaceutical research by helping identify trial-eligible patients and analyze drug performance across populations.
Technical Insight
Tempus's edge is multimodal data: it links genomic sequences, transcriptomics, digitized pathology slides, radiology images, and structured clinical notes for the same patients. Machine learning models trained across these modalities can predict treatment response, detect biomarkers, and surface trial matches. Because much clinical data starts as messy free text and images, a major part of the work is structuring and normalizing it at scale so models have clean, labeled, interoperable inputs.
Strategic Impact
Vendor strategy
Vendor roadmaps influence what features your team can build next.
Cost and budget
Commercial terms and deployment options affect long-term cost and risk.
Risk and safety
Company incentives shape product defaults, safety posture, and openness.
The Future of Tempus AI in Precision Medicine
Precision medicine is heading toward AI that integrates a patient's full molecular and clinical picture to recommend therapy and predict outcomes earlier. Expect more algorithmic diagnostics, broader use beyond cancer, and faster drug development as AI mines real-world evidence. The constraints are data quality, equitable representation across populations, regulatory validation of AI-driven tests, and proving these tools actually improve survival and cost—not just generate more data.
Real-World Implementation
Sequencing a lung cancer patient's tumor and matching an actionable mutation to an FDA-approved targeted therapy
Surfacing relevant clinical trials a cancer patient is eligible for based on their tumor's molecular profile
Helping a pharmaceutical company find and enroll patients with a specific biomarker for a drug trial
Running an algorithmic test on cardiology data to flag patients at elevated risk who need earlier intervention
Risks & Guardrails
Launch announcements may outpace stability in real production workflows.
API pricing or policy shifts can break assumptions overnight.
Single-vendor dependency increases lock-in and migration costs.
Implementation Roadmap
Evaluate providers using your own tasks and datasets.
Review privacy, security, and legal terms before integration.
Maintain a fallback plan across models or vendors.
Monitor release notes so roadmap changes do not surprise teams.
Keep Exploring
Free newsletter
Get the daily AI briefing
Three verified AI stories every weekday morning, written in plain English. Free forever, no ads.
One email each weekday. Unsubscribe in one click. We never sell or share your address.
Test yourself
Take the Tempus AI in Precision Medicine quiz
Instant feedback on every answer, and a shareable certificate with a verifiable ID once you pass a course.
Support free AI education. AI Understanding is a 501(c)(3) nonprofit — no ads, no paywall, ever. Make a donation
Next guide
AI in Veterinary Medicine
Frequently asked questions
What is Tempus AI in Precision Medicine?
Tempus AI builds one of the largest libraries of clinical and molecular data and applies machine learning to it, so doctors can match patients—especially cancer patients—to therapies based on the biology of their disease. It matters because precision medicine replaces one-size-fits-all treatment with data-driven, individualized care.
What is the central goal of precision medicine as Tempus practices it?
Precision medicine tailors therapy to a patient's molecular and clinical profile rather than using one-size-fits-all treatment.
What kind of data does Tempus combine to power its models?
Tempus links genomic, transcriptomic, imaging, and structured clinical data for the same patients to train multimodal models.
In oncology, what does Tempus do after sequencing a tumor?
Tempus identifies actionable mutations and uses AI to match them to targeted therapies, immunotherapies, and relevant clinical trials.
Why is structuring clinical data a major part of Tempus's work?
Real-world clinical data is messy and unstructured, so normalizing it into clean, labeled inputs is essential before models can learn from it.
Beyond oncology, where has Tempus expanded?
Tempus has broadened from cancer into cardiology, neurology, and infectious disease, among other areas.